Rumours Of Panaceas For COVID-19 Abound, But Some Might Do More Harm Than Good

바카라�Only by prescription, it will be sold,바카라� Rajiv Singhal, general secretary of the All India Organisation of Chemists and Druggists (AIOCD), told Outlook. Singhal says his association, which covers about 8.5 lakh chemists, has sent out strict instructions not to give out azithromycin, HCQ, chloroquine, lopanavir and ritonavir unless prescribed by a registered medical practitioner. 바카라�HCQ normally isn바카라�t a medicine in high demand, but early this week there was a sudden spurt in queries,바카라� he adds. 바카라�Rumours are creating the issue. Our doctors are doing a wonderful job and people shouldn바카라�t panic.바카라�

On March 22, the Indian Council for Medical Research (ICMR) had put out a note regarding the recommendation by the National Taskforce for COVID-19 on the use of HCQ as a prophylactic agent. But this was intended for use only in exceptional circumstances that called for the protection of high-risk individuals.

바카라�It is recommended only, and I mean only, for a healthcare worker who is treating a COVID-19 patient,바카라� ICMR chief Balram Bhargava emphasised at a recent briefing. The only other circumstance the recommendation applies to바카라�as a preventive measure바카라�is that of a person caring for a laboratory-confirmed positive case.

Meanwhile, in the US, Trump바카라�s controversial description of HCQ as a potential 바카라�game changer바카라� has drawn criticism. An Arizona man died and his wife became critically ill, apparently after ingesting chloroquine phosphate, which they had been using to clean their fish tanks.

Across the world, researchers are testing several antiviral drugs for their efficacy in treating COVID-19. So far, no therapeutic drugs have proven to be effective against the novel coronavirus. There are more than 20 ongoing treatment studies in China using chloroquine, according to a WHO research blueprint in mid-March. Chloroquine is being evaluated because it was reasonably active in vitro (laboratory experiments) against SARS-CoV, MERS CoV and SARS-CoV-2, the virus that causes COVID 19. But how that translates in vivo isn바카라�t clear, it said. Chloroquine has shown in vitro activity against viruses causing chikungunya, dengue and influenzas, but in-vivo studies in animal models and randomised controlled trials in humans have been largely disappointing, it noted.

The novel coronavirus belongs to the family of SARS (severe acute respiratory syndrome) viruses, but behaves differently. 바카라�The SARS virus receptors are in the lungs, none in the upper respiratory tract. Therefore it did not spread efficiently,바카라� writes T. Jacob John, retired professor of clinical virology, in Current Science. In this case, the virus receptors are in the upper respiratory tract and lungs.

바카라�So, infection spreads easily and is more virulent than flu,바카라� he adds.

Other antivirals, like HIV drugs lopanavir and ritonavir, are being tested based on the learning from the experiments with SARS and MERS바카라�in Saudi Arabia, for instance, there is an ongoing trial using these drugs against MERS.

So far, only the results of an early Chinese trial on hospitalised adult patients with severe COVID-19 at the Jin Yin-tan Hospital in Wuhan are available, and the results aren바카라�t promising바카라�no benefit was observed with the lopinavir바카라�ritonavir treatment beyond standard care, say the researchers, pointing to the need for more trials to confirm or exclude the possibility of a benefit.

In India, the Central Drugs Standard Control Organisation has approved the restricted public health use of lopinavir-ritonavir combination among symptomatic COVID-19 patients. The approval, explains a senior scientist, was based on the need to have some drug to be able to use on compassionate grounds, which is allowed in public health emergencies. 바카라�There are a lot of global trials going on right now. In India, we haven바카라�t yet started any trials,바카라� says the scientist.

By Ajay Sukumaran in Bangalore